Pages
October has been AAC Awareness Month
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/october-has-been-aac-awareness-month
Alan Blair’s retirement
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/alan-blairs-retirement
Newholme Health Centre named as popular choice for new health facilities
https://dchs.nhs.uk/news/newholme-health-centre-named-popular-choice-new-health-facilities
Files
A2 British Heart Foundation Exercise Video and Strength - Booklet 3 (S109)
British Heart Foundation Exercise Video and Strength - Booklet 3
Protocol for the Administration of Lidocaine 10mg per ml Spray to Facilitate IUC Insertion or Removal
PGD Protocol for the Administration of Lidocaine 10mg per ml Spray to Facilitate IUC Insertion or Removal
A5 - Constipation Pathway (P91)
A5 - Constipation Pathway
Guidelines for Locality Managers and 0-19 Clinicians following notification of a child death (G318)
The aim of this document is to provide guidance for 0-19 clinical staff and Locality Managers following notification by the children’s services administration team of the death of a baby, child, or young person.
Triage Template - Appendix 4 (G323)
Triage Template
Disclosure Ref 2024124 - Sub Contracting of Online Online Sexual Health Services.pdf
Disclosure Ref 2024124 - Sub Contracting of Online Online Sexual Health Services
Disclosure Ref 2024134 - Self Declaration July 2021.pdf
Disclosure Ref 2024134 - Self Declaration July 2021
HRP37 Managing Allegations Against Staff PiPoT Policy - Appendix 4 - A Just Culture Guide
HRP37 Managing Allegations Against Staff PiPoT Policy - Appendix 4 - A Just Culture Guide
INR Testing procedure within Derbyshire Community Health Services by Podiatry Surgery at Ilkeston and Buxton Hospitals (S128)
Only podiatric surgery with the relevant equipment, training and framework in place will be able to utilise this procedure. This clinical procedure will support clinical staff in practice to include arrangements with regards the procedure of the taking of the INR test, quality assurance /quality control, Control of Substances Hazardous to Health (COSHH) assessment, Infection control measures, and any relevant Health and Safety issues. In line with recommendations within the Medicines and Healthcare Products Regulatory Agency (MHRA) Device Bulletin “Management and use of In Vitro Diagnostic (IVD) Point of Care Test Devices DB 2010(02) February 2010
A1 - Observational Audit - protected meal times (G50)
Observational Audit - protected meal times